M. Mashayekhi
Immunology · 2011
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 21 citations into it
Whom M. Mashayekhi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Mashayekhi's perspective
Ordered by how strongly the researchers M. Mashayekhi trusts endorse each paper. Same corpus, a different order for every researcher.
- The origin and development of nonlymphoid tissue CD103+ DCs (Journal of Experimental Medicine)
- Type I interferons in host defense. (Immunity)
- Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1 (Journal of Immunology)
- Tolerogenic dendritic cells. (Annual Review of Immunology)
- Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells (Journal of Experimental Medicine)
- Natural innate and adaptive immunity to cancer. (Annual Review of Immunology)
- Taking dendritic cells into medicine (Nature)
- The three Es of cancer immunoediting. (Annual Review of Immunology)
- Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. (Advances in Immunology)
- Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. (Blood)
Their papers
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors (2011) — 1,089 citations